{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:48Z","timestamp":1772120028458,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03393-9","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:03:22Z","timestamp":1684854202000},"page":"357-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["What is the role of CHCHD2 in adrenal tumourigenesis?"],"prefix":"10.1007","volume":"81","author":[{"given":"Angeliki","family":"Karapanagioti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narjes","family":"Nasiri-Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Moustogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George C.","family":"Trigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Zografos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrysanthi","family":"Aggeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Kyriakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodosia","family":"Choreftaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastassios","family":"Philippou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kaltsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Kassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0906-3617","authenticated-orcid":false,"given":"Anna","family":"Angelousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"3393_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12957-015-0527-4","volume":"13","author":"KN Wanis","year":"2015","unstructured":"K.N. Wanis, R. Kanthan, Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature. World J. Surg. Oncol. 13, 117 (2015).","journal-title":"World J. Surg. Oncol."},{"key":"3393_CR2","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","volume":"366","author":"M Fassnacht","year":"2012","unstructured":"M. Fassnacht, M. Terzolo, B. Allolio, E. Baudin, H. Haak, A. Berruti, S. Welin, C. Schade-Brittinger, A. Lacroix, B. Jarzab, H. Sorbye, D.J. Torpy, V. Stepan, D.E. Schteingart, W. Arlt, M. Kroiss, S. Leboulleux, P. Sperone, A. Sundin, I. Hermsen, S. Hahner, H.S. Willenberg, A. Tabarin, M. Quinkler, C. de la Fouchardi\u00e8re, M. Schlumberger, F. Mantero, D. Weismann, F. Beuschlein, H. Gelderblom, H. Wilmink, M. Sender, M. Edgerly, W. Kenn, T. Fojo, H.-H. M\u00fcller, B. Skogseid, FIRM-ACT Study Group. Combination chemotherapy in advanced adrenocortical carcinoma. N. Engl. J. Med 366, 2189 (2012).","journal-title":"N. Engl. J. Med"},{"key":"3393_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2014-3182","volume":"100","author":"F Beuschlein","year":"2015","unstructured":"F. Beuschlein, J. Weigel, W. Saeger, M. Kroiss, V. Wild, F. Daffara, R. Lib\u00e9, A. Ardito, A. Al Ghuzlan, M. Quinkler, A. O\u00dfwald, C.L. Ronchi, R. de Krijger, R.A. Feelders, J. Waldmann, H.S. Willenberg, T. Deutschbein, A. Stell, M. Reincke, M. Papotti, E. Baudin, F. Tissier, H.R. Haak, P. Loli, M. Terzolo, B. Allolio, H.-H. M\u00fcller, M. Fassnacht, Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J. Clin. Endocrinol. Metab. 100, 841 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3393_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/annonc\/mds231","volume":"23","author":"P Berruti","year":"2012","unstructured":"P. Berruti, E. Baudin, H. Gelderblom, H.R. Haak, F. Porpiglia, M. Fassnacht, ESMO Guidelines Working Group. Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23, 131\u20138 (2012).","journal-title":"Ann Oncol"},{"key":"3393_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ecl.2015.02.004","volume":"44","author":"S Espiard","year":"2015","unstructured":"S. Espiard, J. Bertherat, The genetics of adrenocortical tumors. Endocrinol. Metab. Clin. North Am. 44, 311 (2015).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"3393_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","volume":"46","author":"G Assi\u00e9","year":"2014","unstructured":"G. Assi\u00e9, E. Letouz\u00e9, M. Fassnacht, A. Jouinot, W. Luscap, O. Barreau, H. Omeiri, S. Rodriguez, K. Perlemoine, F. Ren\u00e9-Corail, N. Elarouci, S. Sbiera, M. Kroiss, B. Allolio, J. Waldmann, M. Quinkler, M. Mannelli, F. Mantero, T. Papathomas, R. De Krijger, A. Tabarin, V. Kerlan, E. Baudin, F. Tissier, B. Dousset, L. Groussin, L. Amar, E. Clauser, X. Bertagna, B. Ragazzon, F. Beuschlein, R. Lib\u00e9, A. de Reyni\u00e8s, J. Bertherat, Integrated genomic characterization of adrenocortical carcinoma. Nat. Genet. 46, 607 (2014).","journal-title":"Nat. Genet."},{"key":"3393_CR7","first-page":"6475","volume":"18","author":"X Huang","year":"2019","unstructured":"X. Huang, L. Wu, Y. Kuang, X. Li, X. Deng, X. Liang, L. Li, H. Yang, Z. Huang, D. Lu, Z. Luo, Tauroursodeoxycholic acid mediates endoplasmic reticulum stress and autophagy in adrenocortical carcinoma cells. Oncol. Lett. 18, 6475\u20136482 (2019).","journal-title":"Oncol. Lett."},{"key":"3393_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/cdd.2014.194","volume":"22","author":"Y Liu","year":"2015","unstructured":"Y. Liu, H.V. Clegg, P.L. Leslie, J. Di, L.A. Tollini, Y. He, T.-H. Kim, A. Jin, L.M. Graves, J. Zheng, Y. Zhang, CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation. Cell Death Differ. 22, 1035 (2015).","journal-title":"Cell Death Differ."},{"key":"3393_CR9","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/sj.leu.2404688","volume":"21","author":"A Andersson","year":"2007","unstructured":"A. Andersson, C. Ritz, D. Lindgren, P. Ed\u00e9n, C. Lassen, J. Heldrup, T. Olofsson, J. R\u00e5de, M. Fontes, A. Porwit-MacDonald, M. Behrendtz, M. H\u00f6glund, B. Johansson, T. Fioretos, Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 21, 1198 (2007).","journal-title":"Leukemia"},{"key":"3393_CR10","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T S\u00f8rlie","year":"2003","unstructured":"T. S\u00f8rlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C.M. Perou, P.E. L\u00f8nning, P.O. Brown, A.-L. B\u00f8rresen-Dale, D. Botstein, Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. 100, 8418 (2003).","journal-title":"Proc. Natl Acad. Sci."},{"key":"3393_CR11","first-page":"6426","volume":"24","author":"L Ma","year":"2020","unstructured":"L. Ma, L.-H. Zheng, D.-G. Zhang, Z.-M. Fan, CHCHD2 decreases docetaxel sensitivity in breast cancer via activating MMP2. Eur. Rev. Med. Pharmacol. Sci. 24, 6426 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"3393_CR12","first-page":"329","volume":"38","author":"R Xu","year":"2018","unstructured":"R. Xu, S.-Y. Wang, L. Wang, M.-X. Li, Y. Yao, Value of CHCHD2 as a potential marker of non-small cell lung cancer: analysis of 60 cases. Nan Fang. Yi Ke Da Xue Xue Bao 38, 329 (2018).","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"},{"key":"3393_CR13","first-page":"765","volume":"7","author":"Q Cheng","year":"2018","unstructured":"Q. Cheng, D. Qu, Z. Lu, L. Zhang, Knockdown of CHCHD2 inhibits migration and angiogenesis of human renal cell carcinoma: A potential molecular marker for treatment of RCC. Oncol. Lett. 7, 765\u2013772 (2018).","journal-title":"Oncol. Lett."},{"key":"3393_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ccr.2009.07.016","volume":"16","author":"H Pei","year":"2009","unstructured":"H. Pei, L. Li, B.L. Fridley, G.D. Jenkins, K.R. Kalari, W. Lingle, G. Petersen, Z. Lou, L. Wang, FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16, 259 (2009).","journal-title":"Cancer Cell"},{"key":"3393_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","volume":"8","author":"LM Weiss","year":"1984","unstructured":"L.M. Weiss, Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 8, 163 (1984).","journal-title":"Am. J. Surg. Pathol."},{"key":"3393_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s12020-020-02246-z","volume":"68","author":"A Angelousi","year":"2020","unstructured":"A. Angelousi, N. Nasiri-Ansari, A. Karapanagioti, G. Kyriakopoulos, C. Aggeli, G. Zografos, T. Choreftaki, C. Parianos, T. Kounadi, K. Alexandraki, H.S. Randeva, G. Kaltsas, A.G. Papavassiliou, E. Kassi, Expression of clock-related genes in benign and malignant adrenal tumors. Endocrine 68, 650 (2020).","journal-title":"Endocrine"},{"key":"3393_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/nu12010053","volume":"12","author":"N Nasiri Ansari","year":"2019","unstructured":"N. Nasiri Ansari, F. Spentza, G. Dimitriadis, A. Daskalopoulou, A. Karapanagioti, G. Siasos, E. Lianidou, A. Papavassiliou, E. Kassi, H. Randeva, Orexin-A Exerts Equivocal Role in Atherosclerosis Process Depending on the Duration of Exposure: In Vitro Study. Nutrients 12, 53 (2019).","journal-title":"Nutrients"},{"key":"3393_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402 (2001).","journal-title":"Methods"},{"key":"3393_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1067\/msy.2002.128616","volume":"132","author":"H Kanauchi","year":"2002","unstructured":"H. Kanauchi, N. Wada, O.H. Clark, Q.-Y. Duh, Apoptosis regulating genes, bcl-2 and bax, and human telomerase reverse transcriptase messenger RNA expression in adrenal tumors: possible diagnostic and prognostic importance. Surgery 132, 1021 (2002).","journal-title":"Surgery"},{"key":"3393_CR20","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/sj.bjc.6600287","volume":"86","author":"GP Bernini","year":"2002","unstructured":"G.P. Bernini, A. Moretti, P. Viacava, A.G. Bonadio, P. Iacconi, P. Miccoli, A. Salvetti, Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues. Br. J. Cancer 86, 1561 (2002).","journal-title":"Br. J. Cancer"},{"key":"3393_CR21","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3109\/07435809809032715","volume":"24","author":"T Ando","year":"1998","unstructured":"T. Ando, H. Shibata, T. Suzuki, I. Kurihara, K. Hayashi, M. Hayashi, I. Saito, H. Kawabe, M. Tsujioka, T. Saruta, The possible role of apoptosis-suppressing genes, bcl-2 and mcl-1\/EAT in human adrenal tumors. Endocr. Res. 24, 955 (1998).","journal-title":"Endocr. Res."},{"key":"3393_CR22","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1210\/jc.2002-020965","volume":"88","author":"H Kanauchi","year":"2003","unstructured":"H. Kanauchi, N. Wada, D.G. Ginzinger, M. Yu, M.G. Wong, O.H. Clark, Q.-Y. Duh, Diagnostic and prognostic value of fas and telomeric-repeat binding factor-1 genes in adrenal tumors. J. Clin. Endocrinol. Metab. 88, 3690 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3393_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/01.MP.0000073134.60541.E8","volume":"16","author":"PJ Zhang","year":"2003","unstructured":"P.J. Zhang, E.M. Genega, J.E. Tomaszewski, T.L. Pasha, V.A. LiVolsi, The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Mod. Pathol. 16, 591 (2003).","journal-title":"Mod. Pathol."},{"key":"3393_CR24","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.3892\/or.2015.4295","volume":"34","author":"Y Wu","year":"2015","unstructured":"Y. Wu, W. Wang, W. Hu, W. Xu, G. Xiao, Q. Nie, K. Ouyang, S. Chen, MicroRNA-205 suppresses the growth of adrenocortical carcinoma SW-13 cells via targeting Bcl-2. Oncol. Rep. 34, 3104 (2015).","journal-title":"Oncol. Rep."},{"key":"3393_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12890-020-1079-0","volume":"20","author":"X Yin","year":"2020","unstructured":"X. Yin, J. Xia, Y. Sun, Z. Zhang, CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression. BMC Pulm. Med. 20, 40 (2020).","journal-title":"BMC Pulm. Med."},{"key":"3393_CR26","doi-asserted-by":"publisher","first-page":"6822","DOI":"10.7150\/jca.31158","volume":"10","author":"Y Yao","year":"2019","unstructured":"Y. Yao, J. Su, L. Zhao, R. Li, K. Liu, S. Wang, CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients. J. Cancer 10, 6822 (2019).","journal-title":"J. Cancer"},{"key":"3393_CR27","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1200\/JCO.2008.18.5678","volume":"27","author":"A de Reyni\u00e8s","year":"2009","unstructured":"A. de Reyni\u00e8s, G. Assi\u00e9, D.S. Rickman, F. Tissier, L. Groussin, F. Ren\u00e9-Corail, B. Dousset, X. Bertagna, E. Clauser, J. Bertherat, Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J. Clin. Oncol. 27, 1108 (2009).","journal-title":"J. Clin. Oncol."},{"key":"3393_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1530\/EJE-12-0183","volume":"167","author":"CF Lorea","year":"2012","unstructured":"C.F. Lorea, D.A. Moreno, K.S. Borges, C.E. Martinelli, S.R.R. Antonini, M. de Castro, S. Tucci, L. Neder, L.N.Z. Ramalho, I. Cardinalli, A.L. Seidinger, M.J. Mastellaro, J.A. Yunes, S.R. Brandalise, L.G. Tone, C.A. Scrideli, Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis. Eur. J. Endocrinol. 167, 199 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"3393_CR29","doi-asserted-by":"publisher","first-page":"11029","DOI":"10.18632\/oncotarget.2789","volume":"5","author":"R Lamb","year":"2014","unstructured":"R. Lamb, H. Harrison, J. Hulit, D.L. Smith, M.P. Lisanti, F. Sotgia, Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1\/2 inhibition. Oncotarget 5, 11029 (2014).","journal-title":"Oncotarget"},{"key":"3393_CR30","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1093\/hmg\/dds216","volume":"21","author":"M Feyeux","year":"2012","unstructured":"M. Feyeux, F. Bourgois-Rocha, A. Redfern, P. Giles, N. Lefort, S. Aubert, C. Bonnefond, A. Bugi, M. Ruiz, N. Deglon, L. Jones, M. Peschanski, N.D. Allen, A.L. Perrier, Early transcriptional changes linked to naturally occurring Huntington\u2019s disease mutations in neural derivatives of human embryonic stem cells. Hum. Mol. Genet 21, 3883 (2012).","journal-title":"Hum. Mol. Genet"},{"key":"3393_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1059108","volume":"292","author":"MC Wei","year":"2001","unstructured":"M.C. Wei, W.-X. Zong, E.H.-Y. Cheng, T. Lindsten, V. Panoutsakopoulou, A.J. Ross, K.A. Roth, G.R. MacGregor, C.B. Thompson, S.J. Korsmeyer, Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Sci. (80-.) 292, 727 (2001).","journal-title":"Sci. (80-.)"},{"key":"3393_CR32","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.18632\/oncotarget.14067","volume":"8","author":"B Altieri","year":"2017","unstructured":"B. Altieri, S. Sbiera, S. Della Casa, I. Weigand, V. Wild, S. Steinhauer, G. Fadda, A. Kocot, M. Bekteshi, E.M. Mambretti, A. Rosenwald, A. Pontecorvi, M. Fassnacht, C.L. Ronchi, Livin\/BIRC7 expression as malignancy marker in adrenocortical tumors. Oncotarget 8, 9323 (2017).","journal-title":"Oncotarget"},{"key":"3393_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-0032-1327750","volume":"45","author":"S Sbiera","year":"2012","unstructured":"S. Sbiera, M. Kroiss, T. Thamm, M. Beyer, F. Majidi, D. Kuehner, M. Wobser, J. Becker, P. Adam, C. Ronchi, B. Allolio, M. Fassnacht, Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential. Horm. Metab. Res. 45, 137 (2012).","journal-title":"Horm. Metab. Res."},{"key":"3393_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1096\/fj.09-137562","volume":"24","author":"M Seo","year":"2010","unstructured":"M. Seo, W. Lee, K. Suk, Identification of novel cell migration-promoting genes by a functional genetic screen. FASEB J. 24, 464 (2010).","journal-title":"FASEB J."},{"key":"3393_CR35","first-page":"1019","volume":"76","author":"MR Flack","year":"1993","unstructured":"M.R. Flack, Oral gossypol in the treatment of metastatic adrenal cancer. J. Clin. Endocrinol. Metab. 76, 1019 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3393_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/1535-7163.23.4.1","volume":"4","author":"CL Oliver","year":"2005","unstructured":"C.L. Oliver, M.B. Miranda, S. Shangary, S. Land, S. Wang, D.E. Johnson, (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance. Mol. Cancer Ther. 4, 23 (2005).","journal-title":"Mol. Cancer Ther."},{"key":"3393_CR37","first-page":"4805","volume":"30","author":"DE Schteingart","year":"2010","unstructured":"D.E. Schteingart, R. Benitez, C. Bradford, A. Narayan, S. Wang, Expression of anti-apoptosis genes determines the response of adrenal cancer to apoptosis-inducing chemotherapy. Anticancer Res 30, 4805 (2010).","journal-title":"Anticancer Res"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03393-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T08:14:37Z","timestamp":1687767277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03393-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["3393"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03393-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2403182\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by B the institutional Research Ethics Board of the National and Kapodistrian University of Athens (NKUA) (Laiko hospital, code 6545\/22-4-2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}